QuickView for Pro-epidermal growth factor (biogroup)

1. Renal cell carcinomas - Clear cell, papillary, chromophobe, and oncocytoma
2. Acute cellular injury responses in mouse renal ischemic reperfusion injury
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)

There were no matches for Pro-epidermal growth factor

1. Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers
2. Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer
3. Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epiderm…
4. Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell L…
5. A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal …